CAPR - Capricor Therap Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 TVIX (%) SPY (%) SPLK (%) VXX (%) SPX (%) TQQQ (%) ZS (0%) SPOT (%) TLRY (%) TGEN (0%) SYNH (0%) SUPV (0%) QQQ (0%) PNC (0%) PINS (0%) PFE (0%) PANW (0%) MELI (0%) MCD (0%) IWM (0%) GSK (0%) GLD (0%) EW (0%) EKSO (0%) CMI (0%)

CAPR - Capricor Therapeutic...

$2.71 0[0%]

15 mins delayed data

People also watch : EIGR | JNJ | CLBS | PTLA | PTN | BTX

+Watchlist

3 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$2.71	Open
Volume		Market Cap	11.89M
Yield		Last Dividend

Day

52 Week

NuVasive's New TLIF Implant Broadens...	08/22/19
NuVasive's (NUVA) Modulus TLIF-A is designed to work smoothly with the existing MAS TLIF and MAS Midline access systems.

Boston Scientific's (BSX) Vercise Ge...	08/20/19
Boston Scientific's (BSX) Vercise Gevia DBS system should boost neuromodulation revenues for the company.

Here's What We Think About Capricor ...	08/16/19
Linda Marbán became the CEO of Capricor Therapeutics, Inc. (NASDAQ:CAPR) in 2010. This report will, first, examine the...

Capricor Therapeutics (CAPR) Reports Q2 ...	08/06/19
Capricor (CAPR) delivered earnings and revenue surprises of 26.25% and 86.36%, respectively, for the quarter ended June 2019. Do the numbers hold clue...

Capricor Therapeutics Reports Second Qua...	08/06/19
Positive Results from HOPE-2 Interim Analysis Reported in July To Host Conference Call and Webcast Today at 4:30 p.m. ET LOS ANGELES, Aug. 06, 2019 --...

ANALYST RATINGS

1 analyst ratings (Last 6 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Buy rating	07/15/19
H.C. Wainwright maintains Buy rating and raises Price Target from $3.50 to $12.40

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $CAPR

Service Name	Trader	% Success
Big Data Kornacki & Zhou	Zhou Academy	90.00 %	Subscribe
Arbitrage Trade Analytics	Royce Wells	72.00 %	Subscribe
GOFANG	avinash anantharamu	0.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%